[1] Spoendlin J, Voegel JJ, Jick SS, et al. A study on the epidemiology of rosacea in the U.K[J].Br J Dermatol,2012,167(3): 598-605. [2] Tan J, Sch fer H, Araviiskaia E, et al. Prevalence of rosacea in the general population of Germany and Russia-The RISE study[J].J Eur Acad Dermatol Venereol,2016, 30(3): 428-434. [3] Li Jinglin, Wang Ben, Deng Yuxuan,et al. Epidemiological features of rosacea in Changsha, China: A population-based, cross-sectional study[J].J Dermatol,2020,47(5):497-502. [4] Stein L, Kircik L, Fowler J, et al. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies[J].J Drugs Dermatol,2014, 13(3):316-323. [5] Two AM, Wu W, Gallo RL, et al. Rosacea: part II. Topical and systemic therapies in the treatment of rosacea[J].J Am Acad Dermatol,2015, 72(5):761-770. [6] Wang Ben, Yuan Xin, Huang Xin, et al. Efficacy and safety of hydroxychloroquine for treatment of patients with rosacea: a multi-center, randomized, double-blind, double-dummy, pilot study[J].J Am Acad Dermatol,2020,S0190-9622(20):30915-30924. [7] Hsu C, Lee JY. Carvedilol for the treatment of refractory facial flushing and persistent erythema of rosacea[J].Arch Dermatol,2011,147(11):1258-1260. [8] Taub AF, Devita EF. Successful treatment of erythematotelangiectatic rosacea with pulsed light and radiofrequency[J].J Clin Aesthet Dermatol,2008, 1(1): 37-40. [9] Neuhaus IM, Zane LT, Tope WD. Comparative efficacy of nonpurpuragenic pulsed dye laser and intense pulsed light for erythematotelangiectatic rosacea[J].Dermatol Surg,2009, 35(6): 920-928. [10] Zide MF. Surgical removal of rhinophyma[J].J Oral Maxillofac Surg,2008,66(10): 2168-2177.
2020, Vol. 37 
